Lotus Eye Hospital and Institute Limited

NSEI:LOTUSEYE Rapport sur les actions

Capitalisation boursière : ₹1.6b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Lotus Eye Hospital and Institute Gestion

Gestion contrôle des critères 4/4

Le PDG Lotus Eye Hospital and Institute's est Kuttapalayam Ramalingam, nommé en Aug2020, a un mandat de 3.5 ans. détient directement 1.43% des actions de la société, d'une valeur de ₹ 22.54M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.9 ans et 4.7 ans.

Informations clés

Kuttapalayam Ramalingam

Directeur général

₹1.2m

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général4.1yrs
Propriété du PDG1.4%
Durée moyenne d'occupation des postes de direction4yrs
Durée moyenne du mandat des membres du conseil d'administration4.8yrs

Mises à jour récentes de la gestion

Recent updates

Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Aug 21
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Jan 24
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 08
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Jul 15
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

Apr 07
Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Oct 08
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 02
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

Jun 17
If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Mar 11
MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Dec 30
Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

Nov 20
Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Sep 21
The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Aug 27
Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Aug 03
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

Jul 06
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

PDG

Kuttapalayam Ramalingam (74 yo)

4.1yrs

Titularisation

₹1,200,000

Compensation

Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Kuttapalayam Ramalingam
CEO & Executive Director4.1yrs₹1.20m1.43%
₹ 22.3m
Ramanujam Reghunathan
Chief Financial Officer2.3yrs₹1.70mpas de données
Mohanmenon Menon
Company Secretary & Compliance Officer2.6yrs₹1.08mpas de données
Sangeetha Sundaramoorthy
MD & Director4yrs₹3.09m18.84%
₹ 292.4m
Rajkumar Sundaramoorthy
Vice President of Administration6.3yrspas de données0.21%
₹ 3.2m

4.0yrs

Durée moyenne de l'emploi

67yo

Âge moyen

Gestion expérimentée: L'équipe de direction de LOTUSEYE est considérée comme expérimentée (ancienneté moyenne 3.9 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Kuttapalayam Ramalingam
CEO & Executive Director3.6yrs₹1.20m1.43%
₹ 22.3m
Sangeetha Sundaramoorthy
MD & Director4.8yrs₹3.09m18.84%
₹ 292.4m
Rajkumar Sundaramoorthy
Vice President of Administration4.7yrspas de données0.21%
₹ 3.2m
Devarayapuram Kaarthikeyan
Non-Executive Independent Director16.9yrs₹200.00kpas de données
Kavetha Sundaramoorthy
Chairman of the Board8.3yrs₹150.00k18.78%
₹ 291.5m
Yogesh Shah
Non-Executive Independent Director16.9yrs₹200.00kpas de données
Marappa Alagiriswamy
Non-Executive Independent Director12.3yrs₹200.00kpas de données
Sengodagounder Natesan
Independent Director3.7yrs₹200.00kpas de données
Gopalakrishnan Veeramani
Independent Non-Executive Director1.8yrs₹200.00kpas de données
Perumalsamy Mahendran
Independent Non-Executive Director1.6yrs₹175.00kpas de données

4.8yrs

Durée moyenne de l'emploi

75yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de LOTUSEYE sont considérés comme expérimentés (ancienneté moyenne 4.7 ans).